Bioavailability and Bioequivalence: Focus on Physiological Factors and Variability
Vangelis Karalis(National and Kapodistrian University of Athens), Vinod P. Shah, Panos Macheras(National and Kapodistrian University of Athens), Achiel Van Peer(Johnson & Johnson (United States))
Cited by 64
Related Papers
The Integration of Artificial Intelligence into Clinical Practice
|Applied Biosciences|2024|225
Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease
|The American Journal of Medicine|2021|122
3D-Printed Oral Dosage Forms: Mechanical Properties, Computational Approaches and Applications
|Pharmaceutics|2021|78
Bioequivalence of Highly Variable Drugs: A Comparison of the Newly Proposed Regulatory Approaches by FDA and EMA
|Pharmaceutical Research|2011|68
Variational Autoencoders for Data Augmentation in Clinical Studies
|Applied Sciences|2023|54